EDN1 and ischemia: In an endothelin-1 rat model, injection of both global CDK5 Dominant-negative (DNCDK5), cytoplasmic DNCDK5 or nuclei DNCDK5 2 weeks before ischemia decreased infarct volume compared to WT at day 4 [69,72].